Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Dongsheng Group is a prominent Chinese pharmaceutical conglomerate primarily focused on Traditional Chinese Medicine (TCM) and modern healthcare products. The company is best known for its ownership of Guangyuyuan, one of China's oldest TCM brands with a history spanning over 480 years. Dongsheng Group's portfolio includes iconic products such as Guiling Ji and Dingkun Dan, which are recognized as national intangible cultural heritage in China. Beyond traditional remedies, the group has historically engaged in the manufacturing and distribution of modern pharmaceuticals and healthcare supplements. Headquartered in Xi'an, the company operates across the entire value chain from herbal cultivation to retail pharmacy. The group has played a significant role in the modernization and commercialization of ancient Chinese medical formulas for contemporary global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Dongsheng Group.